CVS is badly undervalued


After the strong dip on 1st May upon it’s Q1, the recent price range gives you 4.6-4.8% of dividends if things stay the same. They have a PE ratio below its industry’s average.

Seems like an incoming “David Double Play” once the EPS meets or gets nearer to estimation in either Q2 or Q3. If that didn’t go as planned, there’s at least minimal downside compared to what everyone’s focusing on and overbuying over the months(Mag 7 for example). Aren’t we all about buy low sell high here?

Is there any inherent problem with the business nature that I might overlooking here? Or just because in the short to mid term it’s not expected to beat the market?


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *